EMA — authorised 31 December 2009
- Application: EMEA/H/C/000947
- Marketing authorisation holder: Merck Sharp Dohme Limited
- Local brand name: Vorinostat MSD
- Status: withdrawn
🇪🇺 Zolinza in European Union
EMA authorised Zolinza on 31 December 2009
Marketing authorisation
Zolinza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Zolinza approved in European Union?
Yes. EMA authorised it on 31 December 2009.
Who is the marketing authorisation holder for Zolinza in European Union?
Merck Sharp Dohme Limited holds the EU marketing authorisation.